| CYHS2402184 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs(4) | Generic Drug | 2024-07-16 | | Ningbo Menovo TianKang Pharmaceutical Co Ltd | | | view |
| JYHB2300546 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2023-09-20 | | Sanofi Winthrop Industrie | | | view |
| CYHS2200285 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs(4) | Generic Drug | 2022-02-09 | | Jiangxi Shimei Pharmaceutical Co Ltd | | | view |
| JYHB0900519 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2009-07-03 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Issued | 2010-02-08 | view |
| CYHB2101002 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs(4) | Supplementary Application | 2021-03-03 | | Hunan Jiudian Pharmaceutical Co Ltd;Shandong Xinhua Pharmaceutical Company Limited | | | view |
| CYHS2501228 | 厄贝沙坦氨氯地平片（I） | amlodipine;irbesartan | Tablet | Chemical Drugs(3) | Generic Drug | 2025-03-29 | | Zhejiang AngLiKang Pharmaceutical Co Ltd | | | view |
| JYHB1200426 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2012-05-03 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Issued | 2012-12-26 | view |
| JYHB2300640 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2023-11-08 | | Sanofi Winthrop Industrie | | | view |
| JYHZ2100697 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs | License Renew | 2021-11-15 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JYHB1000215 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2010-03-31 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Issued | 2011-04-08 | view |
| CYHB2200464 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2022-03-15 | | Sanofi (Hangzhou) Pharmaceutical Co Ltd | | | view |
| JYHB0500083 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2005-03-28 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | In Approval | 2006-11-02 | view |
| CYHB2400012 | 厄贝沙坦分散片 | irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2024-01-03 | | Yiling Pharmaceutical Ltd | | | view |
| JYHB0800374 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2008-06-06 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Issued | 2009-01-07 | view |
| JYHB2300381 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2023-07-08 | | Sanofi Winthrop Industrie | | | view |
| CYHL2200045 | 厄贝沙坦氨氯地平片 | amlodipine;irbesartan | Tablet | Chemical Drugs(3) | Generic Drug | 2022-05-27 | | Hunan Huize Biomedical Technology Co Ltd | | | view |
| CYHS2402541 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs(4) | Generic Drug | 2024-08-09 | | Yaopharma Co Ltd | | | view |
| JYHB1200318 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | Supplementary Application | 2012-04-12 | | Sanofi Pharma Bristol-Myers Squibb Snc;Sanofi Winthrop Industrie | Certificate Issued | 2012-08-13 | view |
| JYHS2300123 | 厄贝沙坦片 | irbesartan | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-10-11 | | Hetero Labs Ltd;Yabao Pharmaceutical Group Co Ltd | | | view |
| JYHZ2200222 | 厄贝沙坦氢氯噻嗪片 | hydrochlorothiazide;irbesartan | Tablet | Chemical Drugs | License Renew | 2022-08-17 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
